newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London

  • Eton Pharmaceuticals executive leadership will present at the 2026 Jefferies Global Healthcare Conference in London from November 16-19, 2026.
  • The specific presentation is scheduled for Monday, November 16th, from 3:00-3:25 PM GMT / 10:00-10:25 AM EST.
  • The conference webcast will be available at https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/439Zc3DM73bAusVSPjtSFs.
  • Eton currently markets twelve rare disease products including KHINDIVI, INCRELEX, ALKINDI SPRINKLE, DESMODA, GALZIN, HEMANGEOL, PKU GOLIKE, IMPAVIDO, LIBERVANT, Carglumic Acid, Betaine Anhydrous, & Nitisinone.
  • Six additional product candidates are in late-stage development: AMGLIDIA, ASN-001, ET-700, ET-800, ET-900, & ZENEO hydrocortisone autoinjector.